Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fatenejad

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
International Journal of Clinical Pharmacology and Therapeutics|June 5, 2004
Population-based pharmacokinetics of the soluble TNFr etanercept: a clinical study in 43 patients with ankylosing spondylitis compared with post hoc data from patients with rheumatoid arthritisH Zhou, M Buckwalter, J Boni, et al.
Annals of the Rheumatic Diseases|April 30, 2005
Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO resultsD van der Heijde, L Klareskog, M Boers, et al.
Annals of the Rheumatic Diseases|August 5, 2005
Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trialD van der Heijde, L Klareskog, A Singh, et al.
Annals of the Rheumatic Diseases|April 12, 2006
Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparisonB Combe, C Codreanu, U Fiocco, et al.
Annals of the Rheumatic Diseases|September 17, 2008
Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year studyB Combe, C Codreanu, U Fiocco, et al.
Arthritis and Rheumatism|December 1, 2007
Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritisD van der Heijde, L Klareskog, R Landewé, et al.
Annals of the Rheumatic Diseases|September 4, 2004
Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitisA Calin, B A C Dijkmans, P Emery, et al.
Annals of the Rheumatic Diseases|September 14, 2006
Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitisD van der Heijde, J C Da Silva, M Dougados, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
International Journal of Clinical Pharmacology and Therapeutics|June 5, 2004
Population-based pharmacokinetics of the soluble TNFr etanercept: a clinical study in 43 patients with ankylosing spondylitis compared with post hoc data from patients with rheumatoid arthritisH Zhou, M Buckwalter, J Boni, et al.
Annals of the Rheumatic Diseases|April 30, 2005
Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO resultsD van der Heijde, L Klareskog, M Boers, et al.
Annals of the Rheumatic Diseases|August 5, 2005
Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trialD van der Heijde, L Klareskog, A Singh, et al.
Annals of the Rheumatic Diseases|April 12, 2006
Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparisonB Combe, C Codreanu, U Fiocco, et al.
Annals of the Rheumatic Diseases|September 17, 2008
Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year studyB Combe, C Codreanu, U Fiocco, et al.
Arthritis and Rheumatism|December 1, 2007
Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritisD van der Heijde, L Klareskog, R Landewé, et al.
Annals of the Rheumatic Diseases|September 4, 2004
Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitisA Calin, B A C Dijkmans, P Emery, et al.
Annals of the Rheumatic Diseases|September 14, 2006
Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitisD van der Heijde, J C Da Silva, M Dougados, et al.
Pageof 2